<!-- Generated by pkgdown: do not edit by hand -->
<!DOCTYPE html>
<html>
  <head>
  <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1.0">

<title>Hazard ratios from network meta-analysis — mstate_nma_hr • iviNSCLC</title>

<!-- jquery -->
<script src="https://code.jquery.com/jquery-3.1.0.min.js" integrity="sha384-nrOSfDHtoPMzJHjVTdCopGqIqeYETSXhZDFyniQ8ZHcVy08QesyHcnOUpMpqnmWq" crossorigin="anonymous"></script>
<!-- Bootstrap -->
<link href="https://maxcdn.bootstrapcdn.com/bootswatch/3.3.7/simplex/bootstrap.min.css" rel="stylesheet" crossorigin="anonymous">

<script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.7/js/bootstrap.min.js" integrity="sha384-Tc5IQib027qvyjSMfHjOMaLkfuWVxZxUPnCJA7l2mCWNIpG9mGCD8wGNIcPD7Txa" crossorigin="anonymous"></script>

<!-- Font Awesome icons -->
<link href="https://maxcdn.bootstrapcdn.com/font-awesome/4.6.3/css/font-awesome.min.css" rel="stylesheet" integrity="sha384-T8Gy5hrqNKT+hzMclPo118YTQO6cYprQmhrYwIiQ/3axmI1hQomh7Ud2hPOy8SP1" crossorigin="anonymous">

<!-- clipboard.js -->
<script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/1.7.1/clipboard.min.js" integrity="sha384-cV+rhyOuRHc9Ub/91rihWcGmMmCXDeksTtCihMupQHSsi8GIIRDG0ThDc3HGQFJ3" crossorigin="anonymous"></script>

<!-- sticky kit -->
<script src="https://cdnjs.cloudflare.com/ajax/libs/sticky-kit/1.1.3/sticky-kit.min.js" integrity="sha256-c4Rlo1ZozqTPE2RLuvbusY3+SU1pQaJC0TjuhygMipw=" crossorigin="anonymous"></script>

<!-- pkgdown -->
<link href="../pkgdown.css" rel="stylesheet">
<script src="../pkgdown.js"></script>



<meta property="og:title" content="Hazard ratios from network meta-analysis — mstate_nma_hr" />

<meta property="og:description" content="Hazard ratios for first line treatments relative to gefitinib
estimated using a Bayesian multi-state network meta-analyis (NMA)." />
<meta name="twitter:card" content="summary" />



<!-- mathjax -->
<script src='https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML'></script>

<!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]-->


  </head>

  <body>
    <div class="container template-reference-topic">
      <header>
      <div class="navbar navbar-default navbar-fixed-top" role="navigation">
  <div class="container">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#navbar">
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <span class="navbar-brand">
        <a class="navbar-link" href="../index.html">iviNSCLC</a>
        <span class="label label-danger" data-toggle="tooltip" data-placement="bottom" title="Unreleased package">0.0.0.9000</span>
      </span>
    </div>

    <div id="navbar" class="navbar-collapse collapse">
      <ul class="nav navbar-nav">
        <li>
  <a href="../reference/index.html">API</a>
</li>
<li>
  <a href="../articles/tutorial.html">Tutorial</a>
</li>
<li>
  <a href="../model-doc/model-doc.pdf">PDF documentation</a>
</li>
<li>
  <a href="../articles/source-data.html">Source data</a>
</li>
      </ul>
      
      <ul class="nav navbar-nav navbar-right">
        <li>
  <a href="https://github.com/InnovationValueInitiative/IVI-NSCLC">
    <span class="fa fa-github fa-lg"></span>
     
  </a>
</li>
      </ul>
      
    </div><!--/.nav-collapse -->
  </div><!--/.container -->
</div><!--/.navbar -->

      
      </header>

<div class="row">
  <div class="col-md-9 contents">
    <div class="page-header">
    <h1>Hazard ratios from network meta-analysis</h1>
    <small class="dont-index">Source: <a href='https://github.com/InnovationValueInitiative/IVI-NSCLC/blob/master/R/data.R'><code>R/data.R</code></a></small>
    <div class="hidden name"><code>mstate_nma_hr.Rd</code></div>
    </div>

    <div class="ref-description">
    
    <p>Hazard ratios for first line treatments relative to gefitinib
estimated using a Bayesian multi-state network meta-analyis (NMA).</p>
    
    </div>

    <pre class="usage"><span class='no'>mstate_nma_hr</span></pre>
        
    <h2 class="hasAnchor" id="format"><a class="anchor" href="#format"></a>Format</h2>

    <p>A data.table with the following columns:</p><dl class='dl-horizontal'>
  <dt>line</dt><dd><p>Line of treatment. Either first or second.</p></dd>
  <dt>mutation</dt><dd><p>At 2nd line, equal to 1 if there is a T790M mutation and 
  0 otherwise.</p></dd>
  <dt>model</dt><dd><p>The statistical model.</p></dd> 
  <dt>tx_name</dt><dd><p>Name of the treatment.</p></dd>
  <dt>month</dt><dd><p>Trial month.</p></dd>
  <dt>transition</dt><dd><p>The health state transition.</p></dd>
  <dt>mean</dt><dd><p>Mean hazard ratio from the posterior distribution.</p></dd>
  <dt>l95</dt><dd><p>Lower limit of 95 percent credible interval from posterior distribution.</p></dd>
  <dt>u95</dt><dd><p>Upper limit of the 95 percent credible interval from the posterior distribution.</p></dd>
</dl>
    
    <h2 class="hasAnchor" id="see-also"><a class="anchor" href="#see-also"></a>See also</h2>

    <div class='dont-index'><p><code><a href='mstate_nma_surv.html'>mstate_nma_surv</a></code>, <code><a href='mstate_nma_hazard.html'>mstate_nma_hazard</a></code></p></div>
    

    <h2 class="hasAnchor" id="examples"><a class="anchor" href="#examples"></a>Examples</h2>
    <pre class="examples"><div class='input'><span class='fu'>head</span>(<span class='no'>mstate_nma_hr</span>)</div><div class='output co'>#&gt;    line mutation   model   tx_name month            transition      mean
#&gt; 1:    1       NA Weibull erlotinib     0 Stable to progression 1.0000000
#&gt; 2:    1       NA Weibull erlotinib     1 Stable to progression 0.7544619
#&gt; 3:    1       NA Weibull erlotinib     2 Stable to progression 0.6268211
#&gt; 4:    1       NA Weibull erlotinib     3 Stable to progression 0.5725867
#&gt; 5:    1       NA Weibull erlotinib     4 Stable to progression 0.5412879
#&gt; 6:    1       NA Weibull erlotinib     5 Stable to progression 0.5205627
#&gt;          l95       u95
#&gt; 1: 1.0000000 1.0000000
#&gt; 2: 0.2763996 1.5953927
#&gt; 3: 0.3130116 1.0785119
#&gt; 4: 0.3218246 0.9402807
#&gt; 5: 0.2953620 0.8762432
#&gt; 6: 0.2676107 0.8590506</div></pre>
  </div>
  <div class="col-md-3 hidden-xs hidden-sm" id="sidebar">
    <h2>Contents</h2>
    <ul class="nav nav-pills nav-stacked">
      
      <li><a href="#format">Format</a></li>

      <li><a href="#see-also">See also</a></li>
      
      <li><a href="#examples">Examples</a></li>
    </ul>

  </div>
</div>

      <footer>
      <div class="copyright">
  <p>Developed by Devin Incerti, Jeroen P. Jansen.</p>
</div>

<div class="pkgdown">
  <p>Site built with <a href="http://pkgdown.r-lib.org/">pkgdown</a>.</p>
</div>

      </footer>
   </div>

  

  </body>
</html>

